BioSpace News Archive

CGTN recently looked back on China’s efforts to fight the ongoing new coronavirus outbreak in a recent report and released an original video.

According to a new survey from rare disease company Sobi, 28 per cent of people living with a rare condition, and their caregivers, say the disease has caused a relationship to end.

Ping An Insurance (Group) Company of China, Ltd. (hereafter “Ping An”, the “Company” or the “Group”, HKEX: 02318; SSE: 601318) announced that the Corona Virus Disease 2019 (COVID-19) smart image-reading system was launched on 19 February

Expanded long-term partnership to increase Leica Microsystems’ ability to serve strategic accounts and accelerate growth

Acura Pharmaceuticals, Inc. (OTC: ACUR), , announced today financial results for the three and nine months ended September 30, 2019.

Mersana Therapeutics, Inc. today reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2019.

- Fennec Pharmaceuticals Inc. (Nasdaq: FENC; TSX: FRX), a specialty pharmaceutical company, today announced that the company’s Marketing Authorization Application (MAA) for its investigational drug, sodium thiosulfate (unique formulation) for infusion (tradename to be determined in EU), has passed validation and is now under evaluation by the European Medicines Agency (EMA).

Second Generation Practice of Dr. Michael Barnes, D.D.S., in Newport Beach takes the Crown for February.

GoInvo announced the release of “Understanding Coronavirus”,, the latest in a series of open source research and visualizations related to public health.

Harbour BioMed (HBM) today announced U.S. Food and Drug Administration (FDA) approval of its Investigational New Drug (IND) application to begin clinical studies with HBM4003, its next generation anti-CTLA-4 antibody for the treatment of cancer.